All In Biotech

Free tool

FAERS Monitor: Oncaspar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103411 or its brand name (Oncaspar, Pegaspargase). Reports on generic versions are filed under their own applications.

Reports

12,377

Serious

12,121

98% of reports

Hospitalization

7,575

Death reported

1,593

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia1,611
  • pyrexia785
  • febrile bone marrow aplasia684
  • vomiting611
  • neutropenia597
  • sepsis572
  • abdominal pain516
  • hypotension472
  • hypertriglyceridaemia419
  • pancreatitis418
  • thrombocytopenia418
  • nausea409
  • hyperbilirubinaemia380
  • pneumonia369
  • off label use353

Reports by year received

View as table
YearReports
200439
200543
200643
200748
200823
2009111
201077
201186
2012120
2013121
2014131
2015277
2016499
20171,166
20182,817
2019935
2020810
2021881
20221,708
2023742
2024757
2025528
2026415

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,782 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile bone marrow aplasiaSignal684325.7300.7185,593
hypertriglyceridaemiaSignal419130.9118.750,051
hyperbilirubinaemiaSignal38064.758.522,901
febrile neutropeniaSignal1,61142.340.463,502
pancreatitisSignal41813.512.34,816
sepsisSignal5728.88.13,922
neutropeniaSignal5977.56.93,358
thrombocytopeniaSignal4186.45.81,891
hypotensionSignal4724.03.71,069
pyrexiaSignal7853.93.61,686
abdominal painSignal5163.83.51,059
vomitingSignal6112.22.0412
pneumonia3691.91.8169
nausea4090.90.87
off label use3530.70.653

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.